What is Oscimin Oral Dispersible Tablet?
Oscimin Oral Dispersible Tablet produces many effects in the body, including relief from muscle spasms.
Oscimin Oral Dispersible Tablet also reduces the fluid secretions of many organs and glands in the body, such as the stomach, pancreas, lungs, saliva glands, sweat glands, and nasal passages.
Oscimin Oral Dispersible Tablet is used to treat many different stomach and intestinal disorders, including peptic ulcer and irritable bowel syndrome. It is also used to control muscle spasms in the bladder, kidneys, or digestive tract, and to reduce stomach acid. Oscimin Oral Dispersible Tablet is sometimes used to reduce tremors and rigid muscles in people with symptoms of Parkinson's disease.
Oscimin Oral Dispersible Tablet is also used as a drying agent to control excessive salivation, runny nose, or excessive sweating.
Oscimin Oral Dispersible Tablet may also be used for purposes not listed in this medication guide.
Oscimin Oral Dispersible Tablet indications
Oscimin Oral Dispersible Tablet® is effective as adjunctive therapy in the treatment of peptic ulcer. In acute episodes, Oscimin Oral Dispersible Tablet® injection can be used to control gastric secretion, visceral spasm and hypermotility in spastic colitis, spastic bladder, cystitis, pylorospasm, and associated abdominal cramps. For use as adjunctive therapy in the treatment of irritable bowel syndrome (irritable colon, spastic colon, mucous colitis) and functional gastrointestinal disorders. Also as adjunctive therapy in the treatment of neurogenic bladder and neurogenic bowel disturbances (including the splenic flexure syndrome and neurogenic colon).
Parenterally administered Oscimin Oral Dispersible Tablet® is also effective in reducing gastrointestinal motility to facilitate diagnostic procedures such as endoscopy or hypotonic duodenography. Oscimin Oral Dispersible Tablet® may be used to reduce pain and hypersecretion in pancreatitis, in certain cases of partial heart block associated with vagal activity, and as an antidote for poisoning by anticholinesterase agents.
- IN ANESTHESIA:
- Oscimin Oral Dispersible Tablet® injection is indicated as a pre-operative antimuscarinic to reduce salivary, tracheobronchial, and pharyngeal secretions, to reduce the volume and acidity of gastric secretions, and to block cardiac vagal inhibitory reflexes during induction of anesthesia and intubation. Oscimin Oral Dispersible Tablet® protects against the peripheral muscarinic effects such as bradycardia and excessive secretions produced by halogenated hydrocarbons and cholinergic agents such as physostigmine, neostigmine, and pyridostigmine given to reverse the actions of curariform agents.
- IN UROLOGY:
- Oscimin Oral Dispersible Tablet® injection may also be used intravenously to improve radiologic visibility of the kidneys. It is also indicated along with morphine or other narcotics in symptomatic relief of biliary and renal colic.
How should I use Oscimin Oral Dispersible Tablet?
Use Oscimin Oral Dispersible Tablet spray as directed by your doctor. Check the label on the medicine for exact dosing instructions.
- An extra patient leaflet is available with Oscimin Oral Dispersible Tablet spray. Talk to your pharmacist if you have questions about this information.
- Oscimin Oral Dispersible Tablet spray is usually taken 30 to 60 minutes before a meal. Follow your doctor's instructions for taking Oscimin Oral Dispersible Tablet spray.
- The spray pump must be primed before you use the first dose of Oscimin Oral Dispersible Tablet spray. Remove the plastic cover and point the opening away from yourself and others. Press down firmly and quickly until a fine mist appears (at least 3 sprays).
- To use Oscimin Oral Dispersible Tablet spray, hold the container upright. Open your mouth and bring the container as close as possible. Press down firmly and close your mouth. If necessary, repeat as directed by your doctor.
- Do not swallow immediately after you use the spray. Do not spit or rinse your mouth for 5 to 10 minutes after you use Oscimin Oral Dispersible Tablet spray.
- If you have not used the spray pump for 2 days or more, reprime before using it. Point the opening away from yourself and others and spray 1 time to reprime.
- Wipe the spray tip with a clean tissue and replace the cover.
- Do not use this bottle for more than 30 sprays even if it looks like it still contains medicine. The pump may not deliver the correct amount of medicine after 30 sprays.
- Do not take extra doses or stop using Oscimin Oral Dispersible Tablet spray without first checking with your doctor.
- If you also take antacids, take Oscimin Oral Dispersible Tablet spray before meals and the antacid after meals, unless directed otherwise by your doctor.
- If you miss a dose of Oscimin Oral Dispersible Tablet spray, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.
Ask your health care provider any questions you may have about how to use Oscimin Oral Dispersible Tablet spray.
Uses of Oscimin Oral Dispersible Tablet in details
Oscimin Oral Dispersible Tablet is used to treat a variety of stomach/intestinal problems such as cramps and irritable bowel syndrome. It is also used to treat other conditions such as bladder and bowel control problems, cramping pain caused by kidney stones and gallstones, and Parkinson's disease. In addition, it is used to decrease side effects of certain medications (drugs used to treat myasthenia gravis) and insecticides.
This medication works by decreasing acid production in the stomach, slowing down the natural movements of the gut, and relaxing muscles in many organs (e.g., stomach, intestines, bladder, kidney, gallbladder). Oscimin Oral Dispersible Tablet also lessens the amount of certain body fluids (e.g., saliva, sweat). This medication belongs to a class of drugs known as anticholinergics/antispasmodics.
How to use Oscimin Oral Dispersible Tablet sublingual
Place this medication under the tongue and allow it to dissolve. This medication may also be swallowed whole or chewed. It may be taken with or without meals. Take it as prescribed by your doctor.
Dosage is based on your medical condition and response to therapy. Do not increase your dose or take it more often than prescribed without consulting your doctor. Adults and children 12 years and older should not take more than 1.5 milligrams in 24 hours. Children aged 2 to 12 years should not take more than 0.75 milligrams in 24 hours. Ask your doctor or pharmacist for more information.
Antacids lower the absorption of Oscimin Oral Dispersible Tablet. If you use antacids, take them after meals and take Oscimin Oral Dispersible Tablet before meals; or take antacids at least 1 hour after taking Oscimin Oral Dispersible Tablet.
Drink plenty of fluids while taking this medication unless your doctor directs you otherwise.
Inform your doctor if your condition persists or worsens.
Oscimin Oral Dispersible Tablet description
Oscimin Oral Dispersible Tablet is a chemical compound, a tropane alkaloid it is the levo-isomer to atropine. It is a secondary metabolite of some plants, particularly henbane (Hyoscamus niger.) Oscimin Oral Dispersible Tablet is used to provide symptomatic relief to various gastrointestinal disorders including spasms, peptic ulcers, irritable bowel syndrome, pancreatitis, colic and cystitis. It has also been used to relieve some heart problems, control some of the symptoms of Parkinson's disease, as well as for control of respiratory secretions in end of life care.
Oscimin Oral Dispersible Tablet dosage
Oscimin Oral Dispersible Tablet Dosage
Generic name: Oscimin Oral Dispersible Tablet SULFATE.125mg
Dosage form: tablet
See also:
- Oscimin Oral Dispersible Tablet-DT tablet
- Oscimin Oral Dispersible Tablet-FT Chewable Melt tablet
- Oscimin Oral Dispersible Tablet-SL tablet
- Oscimin Oral Dispersible Tablet-SR tablet
The information at Drugs.com is not a substitute for medical advice. Always consult your doctor or pharmacist.
Usual adult and adolescent dose: 1 to 2 tablets three or four times a day, thirty minutes to one hour before meals and at bedtime, the dosage being adjusted as needed and tolerated.
Note: Geriatric patients may be more sensitive to the effects of the usual adult dose.
Usual dose for children 6 to under 12 years of age: 1/2 to 1 tablet three or four times a day, thirty minutes to one hour before meals and at bedtime. Dosage should be individualized by physician according to patient’s needsand tolerance
Note: This product is not recommended for use in children under six years of age.
More about Oscimin Oral Dispersible Tablet (Oscimin Oral Dispersible Tablet)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Support Group
- En Espanol
- 1 Review - Add your own review/rating
Consumer resources
- Oscimin Oral Dispersible Tablet
- Other brands: Oscimin Oral Dispersible Tablet, Oscimin Oral Dispersible Tablet, Oscimin Oral Dispersible Tablet, Oscimin Oral Dispersible Tablet, More (15) »
Professional resources
- Oscimin Oral Dispersible Tablet (FDA)
- Oscimin Oral Dispersible Tablet Sulfate (AHFS Monograph)
Other formulations
- Oscimin Oral Dispersible Tablet SL
- Oscimin Oral Dispersible Tablet FT
- Oscimin Oral Dispersible Tablet SR
- More (1) »
Related treatment guides
- Anesthesia
- Crohn's Disease
- Endoscopy or Radiology Premedication
- Irritable Bowel Syndrome
- Urinary Incontinence
Oscimin Oral Dispersible Tablet interactions
See also:
What other drugs will affect Oscimin Oral Dispersible Tablet?
Additive adverse effects resulting from cholinergic blockade may occur when Oscimin Oral Dispersible Tablet® (Oscimin Oral Dispersible Tablet) is administered concomitantly with other antimuscarinics, amantadine, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.
Antacids may interfere with the absorption of Oscimin Oral Dispersible Tablet® (Oscimin Oral Dispersible Tablet). Administer Oscimin Oral Dispersible Tablet® (Oscimin Oral Dispersible Tablet) before meals; antacids after meals.
Oscimin Oral Dispersible Tablet side effects
See also:
What are the possible side effects of Oscimin Oral Dispersible Tablet?
Applies to Oscimin Oral Dispersible Tablet: oral conventional tablets and sublingual tablets, oral extended-release capsules and tablets, oral oral solution and elixir, oral orally disintegrating tablets, parenteral injection
Side effects include:
Most adverse effects are manifestations of pharmacologic effects at muscarinic-cholinergic receptors and usually are reversible when therapy is discontinued.
Severity and frequency of adverse effects are dose related and individual intolerance varies greatly; adverse effects occasionally may be obviated by a reduction in dosage but this also may eliminate potential therapeutic effects.
Adverse effects include dry mouth, urinary hesitancy and retention, blurred vision, tachycardia, palpitations, mydriasis, increased ocular tension, loss of taste, headache, nervousness, drowsiness, weakness, fatigue, dizziness, insomnia, nausea, vomiting, impotence, constipation, bloated feeling, abdominal pain, diarrhea, allergic reactions or drug idiosyncrasies, urticaria and other dermal manifestations, ataxia, speech disturbance, mental confusion and/or excitement (especially in geriatric patients), short-term memory loss, hallucinations, and decreased sweating.
Oscimin Oral Dispersible Tablet contraindications
See also:
What is the most important information I should know about Oscimin Oral Dispersible Tablet?
Do not take Oscimin Oral Dispersible Tablet if you are allergic to it, or if you have kidney disease, a bladder or intestinal obstruction, severe ulcerative colitis, toxic megacolon, glaucoma, or myasthenia gravis.
Before taking Oscimin Oral Dispersible Tablet, tell your doctor if you have heart disease, congestive heart failure, a heart rhythm disorder, high blood pressure, overactive thyroid, or hiatal hernia with gastroesophageal reflux disease.
Avoid taking antacids at the same time you take Oscimin Oral Dispersible Tablet. Antacids can make it harder for your body to absorb Oscimin Oral Dispersible Tablet. If you use an antacid, take it after you have taken Oscimin Oral Dispersible Tablet and eaten a meal.
Oscimin Oral Dispersible Tablet may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be alert.
Drinking alcohol can increase drowsiness and dizziness while you are taking Oscimin Oral Dispersible Tablet.
Avoid becoming overheated or dehydrated during exercise and in hot weather. Oscimin Oral Dispersible Tablet can decrease sweating and you may be more prone to heat stroke.
Active ingredient matches for Oscimin Oral Dispersible Tablet:
List of Oscimin Oral Dispersible Tablet substitutes (brand and generic names) | Sort by popularity |
| Unit description / dosage (Manufacturer) | Price, USD |
| Nuspas (Taiwan) | |
| Nuspas 100+10 Tablet (Bioman Pharmaceuticals) | $ 0.03 |
| NUSPAS 20MG/100MG TABLET 1 strip / 10 tablets each (Bioman Pharmaceuticals) | $ 0.18 |
| Nuspas Tablet (Bioman Pharmaceuticals) | $ 0.02 |
| Oin | |
| Oin 500 mg Injection (Odin Healthcare Pvt Ltd) | $ 0.58 |
| Oin 100 mg Injection (Odin Healthcare Pvt Ltd) | $ 0.23 |
| Oin 250 mg Injection (Odin Healthcare Pvt Ltd) | $ 0.42 |
| Oscimin | |
| Oscimin tablet, orally disintegrating .125 mg/1 (Larken Laboratories, Inc. (US)) | |
| Oscimin tablet, extended release .375 mg/1 (Larken Laboratories, Inc. (US)) | |
| Oscimin tablet .125 mg/1 (Larken Laboratories, Inc. (US)) | |
| Oscimin SR | |
| Oscimin SR Tablets | |
| Peptard (India) | |
| 20 mg x 10's (Indchemie) | $ 0.54 |
| Peptard 20mg TAB / 10 (Indchemie) | $ 0.54 |
| PEPTARD 10 MG TABLET 1 strip / 10 tablets each (Indchemie) | $ 0.34 |
| PEPTARD 20 MG INJECTION 1 vial / 1 injection each (Indchemie) | $ 0.86 |
| PEPTARD 20 MG TABLET 1 strip / 10 tablets each (Indchemie) | $ 1.07 |
| PEPTARD tab 20 mg x 10's (Indchemie) | $ 0.98 |
| Peptard 10mg Tablet (Indchemie) | $ 0.03 |
| Peptard 20mg Injection (Indchemie) | $ 0.86 |
| Peptard 20mg Tablet (Indchemie) | $ 0.12 |
| Powecon (Taiwan) | |
| Powecon 0.125 mg | |
| Scopolaminum | |
| Drops; Oral; Hyoscyamine Hydrobromide 6 x | |
| Globules; Oral; Hyoscyamine Hydrobromide 6 x | |
| Granules; Oral; Hyoscyamine Hydrobromide 6 x | |
| Tablet; Oral; Scopolamine Hydrobromide 6 ch | |
| Scopolia Extract | |
| Spalytic (Taiwan) | |
| Spalytic 0.125 mg | |
| Spasdel | |
| Spasdel Drops | |
| Spasdel Elixir | |
| Spazaway (Egypt) | |
| Symax (United States) | |
| Symax Duotab | |
| Symax Duotab tablet, multilayer, extended release .375 mg/1 (Capellon Pharmaceuticals, LLC (US)) | |
| Symax Duotab Controlled-Release Tablets | |
| Symax FasTab | |
| Symax Fastab tablet, orally disintegrating .125 mg/1 (Capellon Pharmaceuticals, LLC (US)) | |
| Symax FasTabs | |
| Symax FasTabs Orally Disintegrating Tablets | |
| Symax SR | |
| Symax SR tablet, extended release .375 mg/1 (Capellon Pharmaceuticals, LLC (US)) | |
| Symax SR Extended-Release Tablets | |
| Symax-SL | |
| Symax-SR | |
See 164 substitutes for Oscimin Oral Dispersible Tablet | |
References
- PubChem. "hyoscyamine". https://pubchem.ncbi.nlm.nih.gov/com... (accessed September 17, 2018).
- DrugBank. "hyoscyamine". http://www.drugbank.ca/drugs/DB00424 (accessed September 17, 2018).
- MeSH. "Parasympatholytics". https://www.ncbi.nlm.nih.gov/mesh/68... (accessed September 17, 2018).
Reviews
The results of a survey conducted on ndrugs.com for Oscimin Oral Dispersible Tablet are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Oscimin Oral Dispersible Tablet. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.User reports
Consumer reported useful
No survey data has been collected yetConsumer reported price estimates
No survey data has been collected yetConsumer reported time for results
No survey data has been collected yetConsumer reported age
No survey data has been collected yetConsumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
